Newborn lung diseases in low- and middle-income countries

Olukemi O. Tongo, Zainab O. Imam

Source: Eur Respir Monogr 2021; 92: 343-349
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Olukemi O. Tongo, Zainab O. Imam. Newborn lung diseases in low- and middle-income countries. Eur Respir Monogr 2021; 92: 343-349

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evidence-implementation gaps in low- and middle-income countries' COPD guidelines
Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Year: 2020


Chronic respiratory diseases (CRDs) in low- and middle-income countries (LMICs): A scoping review of survey methodologies
Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Year: 2020


Pragmatic tuberculosis prevention policies for primary care in low- and middle-income countries
Source: Eur Respir J, 51 (3) 1800315; 10.1183/13993003.00315-2018
Year: 2018



Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review
Source: Eur Respir J 2014; 43: 1763-1775
Year: 2014



Chronic obstructive pulmonary disease (COPD) prevalence surveys in low- and middle-income countries (LMICs): A systematic scoping review of methodologies
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


Latent tuberculosis infection in healthcare workers in low- and middle-income countries: an updated systematic review
Source: Eur Respir J, 53 (4) 1801789; 10.1183/13993003.01789-2018
Year: 2019



The global significance of PRISm: how data from low- and middle-income countries link physiology to inflammation
Source: Eur Respir J, 55 (4) 2000184; 10.1183/13993003.00184-2020
Year: 2020



The global significance of PRISm: how data from low- and middle-income countries link physiology to inflammation
Source: Eur Respir J, 55 (4) 2000354; 10.1183/13993003.00354-2020
Year: 2020



Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries
Source: ERJ Open Res, 8 (1) 00597-2021; 10.1183/23120541.00597-2021
Year: 2022



TB drug resistance in low-incidence countries
Source: Eur Respir Mon 2012; 58: 111-123
Year: 2012


Tuberculosis screening in migrants in selected European countries shows wide disparities
Source: Eur Respir J 2006; 27: 801-807
Year: 2006



Practical challenges and solutions to TB control in a lower–middle-income country: experiences from Mongolia
Source: Breathe, 14 (3) 180; 10.1183/20734735.020218
Year: 2018



Romanian emigrants developing tuberculosis while working in European countries
Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups
Year: 2008


Diagnostic opportunities in low-income countries
Source: International Congress 2016 – PG10 Tuberculosis management: a personalised clinical approach
Year: 2016



Ventilation management in Asian middle–income countries
Source: Virtual Congress 2020 – New insights into mechanical ventilation in the intensive care unit
Year: 2020




Comparison of registries of interstitial lung diseases (ILD) in three European countries
Source: Eur Respir J 2001; 18: Suppl. 33, 440s
Year: 2001

Comparison of tuberculosis surveillance systems in low-incidence industrialised countries
Source: Eur Respir J 2008; 32: 1616-1624
Year: 2008



Drug resistance and tuberculosis elimination in low-incidence countries
Source: Eur Respir J 2014; 44: 1408-1411
Year: 2014


Burden of COPD in some African and Asian countries
Source: Annual Congress 2007 - Environmental and clinical aspects of COPD
Year: 2007